A carregar...

Raltegravir in combination with other antiretroviral agents for the treatment of HIV infection

Raltegravir, an inhibitor of the HIV-1 integrase enzyme, is the first available agent in a new class of antiretroviral drugs. Raltegravir has been studied extensively in clinical trials, and has been well tolerated and highly effective in both treatment-naïve and -experienced patients. Resistance to...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Main Authors: Chirch, Lisa M, Steigbigel, Roy T
Formato: Artigo
Idioma:Inglês
Publicado em: Dove Medical Press 2010
Assuntos:
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC3108745/
https://ncbi.nlm.nih.gov/pubmed/21694890
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!